Investigating the Genetic Diversity of H5 Avian Influenza Viruses in the United Kingdom from 2020-2022.

Autor:	Byrne AMP; Virology Department, Animal and Plant Health Agency, Addlestone, Surrey, United Kingdom., James J; Virology Department, Animal and Plant Health Agency, Addlestone, Surrey, United Kingdom.; WOAH/FAO International Reference Laboratory for Avian Influenza, Swine Influenza and Newcastle Disease, Animal and Plant Health Agency (APHA-Weybridge), Addlestone, Surrey, United Kingdom., Mollett BC; Virology Department, Animal and Plant Health Agency, Addlestone, Surrey, United Kingdom., Meyer SM; Virology Department, Animal and Plant Health Agency, Addlestone, Surrey, United Kingdom.; WOAH/FAO International Reference Laboratory for Avian Influenza, Swine Influenza and Newcastle Disease, Animal and Plant Health Agency (APHA-Weybridge), Addlestone, Surrey, United Kingdom., Lewis T; Virology Department, Animal and Plant Health Agency, Addlestone, Surrey, United Kingdom.; WOAH/FAO International Reference Laboratory for Avian Influenza, Swine Influenza and Newcastle Disease, Animal and Plant Health Agency (APHA-Weybridge), Addlestone, Surrey, United Kingdom., Czepiel M; Virology Department, Animal and Plant Health Agency, Addlestone, Surrey, United Kingdom.; WOAH/FAO International Reference Laboratory for Avian Influenza, Swine Influenza and Newcastle Disease, Animal and Plant Health Agency (APHA-Weybridge), Addlestone, Surrey, United Kingdom., Seekings AH; Virology Department, Animal and Plant Health Agency, Addlestone, Surrey, United Kingdom., Mahmood S; Virology Department, Animal and Plant Health Agency, Addlestone, Surrey, United Kingdom., Thomas SS; Virology Department, Animal and Plant Health Agency, Addlestone, Surrey, United Kingdom., Ross CS; Virology Department, Animal and Plant Health Agency, Addlestone, Surrey, United Kingdom., Byrne DJF; School of Biological Sciences, University of Manchester, Manchester, United Kingdom., McMenamy MJ; Agri-Food and Bioscience Institute, Belfast, United Kingdom., Bailie V; Agri-Food and Bioscience Institute, Belfast, United Kingdom., Lemon K; Agri-Food and Bioscience Institute, Belfast, United Kingdom., Hansen RDE; Veterinary Exotics and Notifiable Disease Unit, Animal and Plant Health Agency, Addlestone, Surrey, United Kingdom., Falchieri M; Virology Department, Animal and Plant Health Agency, Addlestone, Surrey, United Kingdom., Lewis NS; Department of Pathology and Population Sciences, Royal Veterinary College, University of London, Hertfordshire, United Kingdom.; Worldwide Influenza Centre, The Francis Crick Institute, London, United Kingdom., Reid SM; Virology Department, Animal and Plant Health Agency, Addlestone, Surrey, United Kingdom., Brown IH; Virology Department, Animal and Plant Health Agency, Addlestone, Surrey, United Kingdom.; WOAH/FAO International Reference Laboratory for Avian Influenza, Swine Influenza and Newcastle Disease, Animal and Plant Health Agency (APHA-Weybridge), Addlestone, Surrey, United Kingdom., Banyard AC; Virology Department, Animal and Plant Health Agency, Addlestone, Surrey, United Kingdom.; WOAH/FAO International Reference Laboratory for Avian Influenza, Swine Influenza and Newcastle Disease, Animal and Plant Health Agency (APHA-Weybridge), Addlestone, Surrey, United Kingdom.
Jazyk:	angličtina
Zdroj:	Microbiology spectrum [Microbiol Spectr] 2023 Aug 17; Vol. 11 (4), pp. e0477622. Date of Electronic Publication: 2023 Jun 26.
DOI:	10.1128/spectrum.04776-22
Abstrakt:	Since 2020, the United Kingdom and Europe have experienced annual epizootics of high-pathogenicity avian influenza virus (HPAIV). The first epizootic, during the autumn/winter of 2020-2021, involved six H5Nx subtypes, although H5N8 HPAIV dominated in the United Kingdom. While genetic assessments of the H5N8 HPAIVs within the United Kingdom demonstrated relative homogeneity, there was a background of other genotypes circulating at a lower degree with different neuraminidase and internal genes.  Following a small number of detections of H5N1 in wild birds over the summer of 2021, the autumn/winter of 2021-2022 saw another European H5 HPAIV epizootic that dwarfed the prior epizootic. This second epizootic was dominated almost exclusively by H5N1 HPAIV, although six distinct genotypes were defined. We have used genetic analysis to evaluate the emergence of different genotypes and proposed reassortment events that have been observed. The existing data suggest that the H5N1 viruses circulating in Europe during late 2020 continued to circulate in wild birds throughout 2021, with minimal adaptation, but then went on to reassort with AIVs in the wild bird population. We have undertaken an in-depth genetic assessment of H5 HPAIVs detected in the United Kingdom over two winter seasons and demonstrate the utility of in-depth genetic analyses in defining the diversity of H5 HPAIVs circulating in avian species, the potential for zoonotic risk, and whether incidents of lateral spread can be defined over independent incursions of infections from wild birds. This provides key supporting data for mitigation activities. IMPORTANCE High-pathogenicity avian influenza virus (HPAIV) outbreaks devastate avian species across all sectors, having both economic and ecological impacts through mortalities in poultry and wild birds, respectively. These viruses can also represent a significant zoonotic risk. Since 2020, the United Kingdom has experienced two successive outbreaks of H5 HPAIV. While H5N8 HPAIV was predominant during the 2020-2021 outbreak, other H5 subtypes were also detected. The following year, there was a shift in the subtype dominance to H5N1 HPAIV, but multiple H5N1 genotypes were detected. Through the thorough utilization of whole-genome sequencing, it was possible to track and characterize the genetic evolution of these H5 HPAIVs in United Kingdom poultry and wild birds. This enabled us to assess the risk posed by these viruses at the poultry-wild bird and the avian-human interfaces and to investigate the potential lateral spread between infected premises, a key factor in understanding the threat to the commercial sector. Competing Interests: The authors declare no conflict of interest.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu